DE69803178D1 - Verfahren zur reduktion von 1-substituierte-3-hydroxymethyl-4-(4-fluorophenyl) tetrahydropyridine - Google Patents

Verfahren zur reduktion von 1-substituierte-3-hydroxymethyl-4-(4-fluorophenyl) tetrahydropyridine

Info

Publication number
DE69803178D1
DE69803178D1 DE69803178T DE69803178T DE69803178D1 DE 69803178 D1 DE69803178 D1 DE 69803178D1 DE 69803178 T DE69803178 T DE 69803178T DE 69803178 T DE69803178 T DE 69803178T DE 69803178 D1 DE69803178 D1 DE 69803178D1
Authority
DE
Germany
Prior art keywords
tetrahydropyridine
fluorophenyl
hydroxymethyl
substituted
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69803178T
Other languages
English (en)
Other versions
DE69803178T2 (de
Inventor
Patrick Brennan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aesica Pharmaceuticals Ltd
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of DE69803178D1 publication Critical patent/DE69803178D1/de
Publication of DE69803178T2 publication Critical patent/DE69803178T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69803178T 1997-05-17 1998-05-13 Verfahren zur reduktion von 1-substituierte-3-hydroxymethyl-4-(4-fluorophenyl) tetrahydropyridine Expired - Lifetime DE69803178T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710004.4A GB9710004D0 (en) 1997-05-17 1997-05-17 Chemical process
PCT/EP1998/002826 WO1998052920A1 (en) 1997-05-17 1998-05-13 Chemical process for the reduction of 1-substituted -3-hydroxymethyl-4- (4-fluorophenyl)tetrahydropyridines

Publications (2)

Publication Number Publication Date
DE69803178D1 true DE69803178D1 (de) 2002-02-21
DE69803178T2 DE69803178T2 (de) 2002-10-31

Family

ID=10812456

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69803178T Expired - Lifetime DE69803178T2 (de) 1997-05-17 1998-05-13 Verfahren zur reduktion von 1-substituierte-3-hydroxymethyl-4-(4-fluorophenyl) tetrahydropyridine

Country Status (28)

Country Link
US (1) US6326496B1 (de)
EP (1) EP0983237B1 (de)
JP (1) JP4463883B2 (de)
KR (1) KR100515852B1 (de)
CN (1) CN1121386C (de)
AR (1) AR012688A1 (de)
AT (1) ATE212013T1 (de)
AU (1) AU748902B2 (de)
BG (1) BG63847B1 (de)
BR (1) BR9809809B1 (de)
CA (1) CA2289013C (de)
CZ (1) CZ292282B6 (de)
DE (1) DE69803178T2 (de)
DK (1) DK0983237T3 (de)
ES (1) ES2171299T3 (de)
GB (1) GB9710004D0 (de)
HU (1) HUP0002709A3 (de)
ID (1) ID24181A (de)
IL (1) IL132360A (de)
NO (1) NO313326B1 (de)
NZ (1) NZ501692A (de)
PL (1) PL189464B1 (de)
PT (1) PT983237E (de)
RU (1) RU2205178C2 (de)
SK (1) SK149599A3 (de)
TR (1) TR199902823T2 (de)
UA (1) UA61952C2 (de)
WO (1) WO1998052920A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085688A1 (en) * 2000-05-12 2001-11-15 Synthon B.V. TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
GB0021147D0 (en) 2000-08-30 2000-10-11 Knoll Ag Chemical process
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
JP2006512278A (ja) 2001-06-13 2006-04-13 テバ ファーマシューティカル インダストリーズ リミティド アルコキシ不純物を実質的に含有しないパロキセチンの製造方法
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
EP1948646A2 (de) * 2005-11-14 2008-07-30 Auspex Pharmaceuticals Inc. Substituierte phenylpiperidine mit serotoninerger aktivität und verbesserten therapeutischen eigenschaften
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849542A (en) 1966-05-09 1974-11-19 Dow Chemical Co Lithium magnesium aluminum hydride
GB1422263A (en) 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
EP0299549A3 (de) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiäre 2,5-Dialkyl-3-phenyl-piperidin-Derivate mit Opiatantagonistischer Wirkung
GB9100505D0 (en) * 1991-01-10 1991-02-20 Shell Int Research Piperidine derivatives
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9305175D0 (en) * 1993-03-13 1993-04-28 Smithkline Beecham Plc Novel process
NZ307479A (en) 1995-05-17 1999-08-30 Novo Nordisk As A process for preparing 4-(4-halo substituted phenyl)-3-(3,4-methylenedioxy phenoxy methyl)piperidine derivatives
EP1384711A1 (de) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Optische Trennung eines Piperidin-Derivates
HU221921B1 (hu) 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process

Also Published As

Publication number Publication date
IL132360A0 (en) 2001-03-19
ATE212013T1 (de) 2002-02-15
NZ501692A (en) 2001-05-25
NO995619L (no) 1999-11-16
DE69803178T2 (de) 2002-10-31
CA2289013C (en) 2007-11-13
US6326496B1 (en) 2001-12-04
RU2205178C2 (ru) 2003-05-27
AU748902B2 (en) 2002-06-13
CZ292282B6 (cs) 2003-08-13
AR012688A1 (es) 2000-11-08
KR20010012620A (ko) 2001-02-26
NO313326B1 (no) 2002-09-16
PL336796A1 (en) 2000-07-17
ID24181A (id) 2000-07-13
BG103834A (en) 2000-07-31
HUP0002709A3 (en) 2002-01-28
CN1255916A (zh) 2000-06-07
ES2171299T3 (es) 2002-09-01
UA61952C2 (en) 2003-12-15
WO1998052920A1 (en) 1998-11-26
JP4463883B2 (ja) 2010-05-19
BR9809809A (pt) 2000-06-27
CN1121386C (zh) 2003-09-17
AU7912198A (en) 1998-12-11
PL189464B1 (pl) 2005-08-31
PT983237E (pt) 2002-05-31
KR100515852B1 (ko) 2005-09-21
SK149599A3 (en) 2000-05-16
IL132360A (en) 2003-02-12
CZ408199A3 (cs) 2000-04-12
DK0983237T3 (da) 2002-03-25
TR199902823T2 (xx) 2000-05-22
EP0983237A1 (de) 2000-03-08
JP2001525838A (ja) 2001-12-11
EP0983237B1 (de) 2002-01-16
HUP0002709A1 (hu) 2001-01-29
BR9809809B1 (pt) 2009-05-05
GB9710004D0 (en) 1997-07-09
NO995619D0 (no) 1999-11-16
BG63847B1 (bg) 2003-03-31
CA2289013A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
DE69603255D1 (de) Verfahren zur modifizierung von oberflächen
DE69812693D1 (de) Verfahren zur oligomerisierung von isobuten
DE69824312D1 (de) Verfahren und gerät zur beendigung von tachyarrhythmien
DE69709061D1 (de) Verfahren zur umsetzung von ethylbenzol
DE69535022D1 (de) Verfahren zur verbesserung von destillat
DE69718027T2 (de) Verfahren zur bekämpfung von unkräutern
DE69725000D1 (de) Verfahren zur druckformung von gegenständen
DE69715424T2 (de) Verfahren zur halogenierung von isoolefin-para-alkylstyrol-copolymeren
DE59703453D1 (de) Verfahren zur reduktion von stickoxiden
DE69727395D1 (de) Verfahren zur olefinisomerisierung
DE69630686D1 (de) Verfahren zur echtheitsprüfung von münzen
DE59900006D1 (de) Verfahren zur Isolierung von gekrümmten Flächen
DE69715884D1 (de) Verfahren zur reinigung von lactamen
ATE220558T1 (de) Verbessertes verfahren zur stabilisierung von proteinen
DE69529343T2 (de) Verfahren zur isolierung von mesophasepech
DE59806044D1 (de) Verfahren zur ermittlung von segmentzeiten
ATE319687T1 (de) Verfahren zur herstellung von substituierten pyridinen
DE69837952D1 (de) Verfahren zur Verwaltung von Fernmeldeleitungen
ATE353879T1 (de) Verfahren zur herstellung von chinolinderivaten
DE69803178D1 (de) Verfahren zur reduktion von 1-substituierte-3-hydroxymethyl-4-(4-fluorophenyl) tetrahydropyridine
DE59709984D1 (de) Verfahren zur tränkung von bauteilen
ATE238994T1 (de) Verfahren zur herstellung von n-substituierten 3- hydroxypyrazolen
ATA96197A (de) Verfahren zur reinigung von schadstoffbelasteten gasen
DE69824283D1 (de) Verfahren zur reinigung von caprolactam
ATE206392T1 (de) Verfahren zur alkylierug von gehinderten sulfonamiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AESICA PHARMACEUTICALS LTD., CRAMLINGTON, NORTHUMB